R. Watson

Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.

R. Jalan, D. Valla, M. Stepanova, 2017, Journal of hepatology.

Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949].

R. Jalan, D. Valla, M. Stepanova, 2018, Journal of Hepatology.

MP0533: A Multispecific Darpin CD3 Engager Targeting CD33, CD123, and CD70 for the Treatment of AML and MDS Designed to Selectively Target Leukemic Stem Cells

D. Steiner, V. Kirkin, M. Hänggi, 2022, Blood.